Literature DB >> 10199856

Effect of NO on transmural distribution of blood flow in hypertrophied left ventricle during exercise.

D J Duncker1, J H Traverse, Y Ishibashi, R J Bache.   

Abstract

When exercise in the presence of a coronary artery stenosis results in subendocardial ischemia, administration of a nitric oxide (NO) donor increases subendocardial blood flow, whereas NO synthesis blockade worsens subendocardial hypoperfusion. Because left ventricular hypertrophy (LVH) is also associated with subendocardial hypoperfusion during exercise, this study tested the hypothesis that alterations of NO availability can similarly influence subendocardial blood flow in the hypertrophied heart. Studies were performed in seven dogs in which ascending aortic banding resulted in an 80% increase in LV weight. Myocardial blood flow was measured with microspheres during treadmill exercise that increased heart rates to 216 +/- 8 beats/min. During control exercise, mean myocardial blood flow in animals with LVH was similar to that in historic controls, but the ratio of subendocardial to subepicardial blood flow was lower in animals with hypertrophy (0.88 +/- 0.07) than in controls (1.36 +/- 0.08; P < 0.05). Blockade of NO synthesis with NG-nitro-L-arginine (L-NNA; 1.5 mg/kg ic) caused no change in heart rate or LV systolic pressure during exercise. Furthermore, L-NNA did not worsen subendocardial hypoperfusion during exercise. Intracoronary infusion of nitroglycerin (0.4 microgram. kg-1. min-1) did not significantly alter either mean blood flow or the transmural distribution of perfusion during exercise in the hypertrophied hearts. Thus, unlike the subendocardial underperfusion that occurs when a stenosis limits coronary blood flow, alterations of NO availability did not alter subendocardial hypoperfusion in the hypertrophied hearts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199856     DOI: 10.1152/ajpheart.1999.276.4.H1305

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Quantitative evaluation of longitudinal strain in layer-specific myocardium in patients with preeclampsia.

Authors:  Juan Cong; Yong Lee; Xiuxiu Fu; Zhibin Wang; Wugang Wang; Junfang Lee
Journal:  Int J Cardiovasc Imaging       Date:  2017-08-03       Impact factor: 2.357

2.  Endocardial and epicardial myocardial perfusion determined by semi-quantitative and quantitative myocardial perfusion magnetic resonance.

Authors:  Abdulghani Larghat; John Biglands; Neil Maredia; John P Greenwood; Stephen G Ball; Michael Jerosch-Herold; Aleksandra Radjenovic; Sven Plein
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-29       Impact factor: 2.357

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo.

Authors:  Biao Lei; Ken Matsuo; Volodymyr Labinskyy; Naveen Sharma; Margaret P Chandler; Anna Ahn; Thomas H Hintze; William C Stanley; Fabio A Recchia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

5.  Multilayer longitudinal strain at rest may help to predict significant stenosis of the left anterior descending coronary artery in patients with suspected non-ST-elevation acute coronary syndrome.

Authors:  Chong Liu; Jing Li; Min Ren; Zhen-Zhen Wang; Zi-Yao Li; Fei Gao; Jia-Wei Tian
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-13       Impact factor: 2.357

6.  Myocardial deformation after radiotherapy: a layer-specific and territorial longitudinal strain analysis in a cohort of left-sided breast cancer patients (BACCARAT study).

Authors:  Valentin Walker; Olivier Lairez; Olivier Fondard; Gaëlle Jimenez; Jérémy Camilleri; Loïc Panh; David Broggio; Marie-Odile Bernier; Dominique Laurier; Jean Ferrières; Sophie Jacob
Journal:  Radiat Oncol       Date:  2020-08-20       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.